Development of chitosan-ellagic acid films as a local drug delivery system to induce apoptotic death of human melanoma cells

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 90 B, Issue 1, 2009, Pages 145-155

  Kim, Sungwoo ^a   Liu, Yongxing ^a   Gaber, M Waleed ^a   Bumgardner, Joel D ^b   Haggard, Warren O ^b   Yang, Yunzhi ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b University of Memphis   (United States)

Author keywords

Apoptosis; Cancer; Chitosan; Ellagic acid; Fibroblasts; Melanoma

Indexed keywords

ACIDS; AMIDES; ANGLE MEASUREMENT; CELL CULTURE; CELL DEATH; CELL MEMBRANES; CHEMOTHERAPY; CHITIN; CHITOSAN; CONTACT ANGLE; DIFFRACTION; DRUG DELIVERY; ESTERS; FIBROBLASTS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SPECTROSCOPIC ANALYSIS; SPECTROSCOPY; SURFACE ROUGHNESS; X RAY DIFFRACTION;

ANTICANCER DRUG; ANTIPROLIFERATIVE EFFECT; APOPTOSIS; APOPTOSIS ASSAYS; APOPTOTIC; APOPTOTIC CELL DEATH; CANCER; CELL BEHAVIORS; CELL RESPONSE; CHITOSAN FILM; CONCENTRATION OF; DIFFRACTION PEAKS; DRUG CARRIER; ELLAGIC ACID; ESTER GROUPS; FIBROBLAST CELLS; LOCAL DRUG DELIVERY; LOCALIZED EFFECTS; MELANOMA; MELANOMA CELLS; SEM; SKIN CANCERS;

COMPOSITE FILMS;

AMIDE; CHITOSAN; ELLAGIC ACID; ESTER DERIVATIVE; WATER;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTACT ANGLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HYDROPHILICITY; INFRARED SPECTROSCOPY; MELANOMA CELL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

APOPTOSIS; CELL ADHESION; CELL LINE; CELL LINE, TUMOR; CHITOSAN; DRUG DELIVERY SYSTEMS; ELLAGIC ACID; FIBROBLASTS; HUMANS; INFANT, NEWBORN; MELANOMA; MICROSCOPY, ELECTRON, SCANNING; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 67650783898     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31266     Document Type: Article

References (47)

1. Stoclet JC, Chataigneau T, Ndiaye M, Oak MH, Bedoui JE, Chataigneau M, Schini-Kerth VB. Vascular protection by dietary polyphenols. Eur J Pharmacol 2004;500:299-313.
2. Mertens-Talcott SU, Talcott ST, Percival SS. Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J Nutr 2003;133:2669-2674.
3. Lazze MC, Savio M, Pizzala R, Cazzalini O, Perucca P, Scovassi AI, Stivala LA, Bianchi L. Anthocyanins induce cell cycle perturbations and apoptosis in different human cell lines. Carcinogenesis 2004;25:1427-1433. (Pubitemid 39162708)
4. Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H. Resveratrol causes WAF-1/p21-mediated G1-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 2001;7:1466-1473. (Pubitemid 32708704)
5. Losso JN, Bansode RR, Trappey A, Bawadi HA, Truax R. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 2004;15:672-678.
6. Narayanan BA, Geoffroy O, Willingham MC, Re GG, Nixon DW. p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett 1999;136:215-221. (Pubitemid 29167185)
7. Whitley AC, Stoner GD, Darby MV, Walle T. Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid-extensive binding to protein and DNA. Biochem Pharmacol 2003;66:907-915. (Pubitemid 37083587)
8. Labrecque L, Lamy S, Chapus A, Mihoubi S, Durocher Y, Cass B, Bojanowski MW, Gingras D, Be'liveau R. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary- derived phenolic compound. Carcinogenesis 2005;26: 821-826.
9. Gopalakrishna R, Gundimeda U. Antioxidant regulation of protein kinase C in cancer prevention. J Nutr 2002;132:3819-3823. (Pubitemid 35435072)
10. Chen FA, Kuriakose MA, Zhou MX, DeLacure MD, Dunn RL. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model. Head Neck 2003; 25:554-560.
11. Castro DJ, Sridhar KS, Garewal HS, Mills GM, Wenig BL, Dunphy FR, Costantino PD, Leavitt RD, Stewart ME, Orenberg EK. Intratumoral cisplatin/epinephrine gel in advanced head and neck cancer: A multicenter, randomized, doubleblind, phase III study in North America. Head Neck 2003; 25:717-731.
12. Withrow SJ, Liptak JM, Straw RC, Dernell WS, Jameson VJ, Powers BE, Johnson JL, Brekke JH, Douple EB. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Ann Surg Oncol 2004;11:705-713.
13. Brem H, Gabikian P. Biodegradable polymer implants to treat brain tumors. J Control Release 2001;74:63-67. (Pubitemid 32727609)
14. Hammoud DA, Belden CJ, Ho AC, Dal Pan GJ, Herskovits EH, Hilt DC, Brem H, Pomp MG. The surgical bed after BCNU polymer wafer placement for recurrent glioma: Serial assessment on CT and MR imaging. Am J Roentgenol 2003; 180:1469-1475. (Pubitemid 36504646)
15. Ewend MG, Williams JA, Tabassi K, Tyler BM, Babel KM, Anderson RC, Pinn ML, Brat DJ, Brem H. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models. Cancer Res 1996;56:5217-5223. (Pubitemid 26383039)
16. Olivi A, Grossman SA, Tatter S, Barker F, Judy K, Olsen J, Bruce J, Hilt D, Fisher J, Piantadosi S. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: A new approaches to brain tumor therapy CNS consortium trial. J Clin Oncol 2003;21:1845-1849. (Pubitemid 46638598)
17. Dhanikula AB, Panchagnula R. Development and characterization of biodegradable chitosan films for local delivery of paclitaxel. AAPS J 2004;6:1-12. (Pubitemid 41554265)
18. Keskar V, Mohanty PS, Gemeinhart EJ, Gemeinhart RA. Cervical cancer treatment with a locally insertable controlled release delivery system. J Control Release 2006;115:280-288. (Pubitemid 44634846)
19. Harper E, Dang W, Lapidus RG, Garver RI. Enhanced effi- cacy of a novel controlled release paclitaxel formulation (PACLIMER Delivery System) for local-regional therapy of lung cancer tumor nodules in mice. Clin Cancer Res 1999; 5:4242-4248. (Pubitemid 30013811)
20. Vogl TJ, Engelmann K, Mack MG, Straub R, Zangos S, Eichler K, Hochmuth K, Orenberg E. CT-guided intratumoural administration of cisplatin/epinephrine gel for treatment of malignant liver tumours. Br J Cancer 2002;86:524-529. (Pubitemid 34185086)
21. Lu Z, Yeh TK, Tsai M, Au JL, Wientjes MG. Paclitaxelloaded gelatin nanoparticles for intravesical bladder cancer therapy clinical. Cancer Res 2004;10:7677-7684. (Pubitemid 39557532)
22. Colevas AD. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 2006;24:2644-2652. (Pubitemid 46628471)
23. Smith M, Abrams J, Trimble EL, Ungerleider RS. Dose intensity of chemotherapy for childhood cancers. Oncologist 1996; 1:293-304. (Pubitemid 126669236)
24. Lin X, Zhang Q, Rice JR, Stewart DR, Nowotnik DP, Howell SB. Improved targeting of platinum chemotherapeutics: The antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour models. Eur J Cancer 2004;40:291-297. (Pubitemid 38077033)
25. Gianasi E, Wasil M, Evagorou EG, Keddle A, Wilson G, Duncan R. HPMA copolymer platinates as novel antitumour agents: In vitro properties, harmacokinetics and antitumour activity in vivo. Eur J Cancer 1999;35:994-1002.
26. Tien CL, Lacroix M, Ispas-Szabo P, Mateescu MA. N-acylated chitosan: Hydrophobic matrices for controlled drug release. J Control Release 2003;93:1-13. (Pubitemid 37346264)
27. Ravi Kumar MN, Hudson SM. Chitosan. In: Wnek G, Bowlin G, editors. Encyclopedia of Biomaterials and Biomedical Engineering (EBBE). New York: Marcel Dekker, Inc.; 2006. pp 310-323.
28. Jaworska M, Sakurai K, Gaudon P, Guibal E. Influence of chitosan characteristics on polymer properties. I. Crystallographic properties. Polym Int 2003;52:198-205.
29. Yuan Y, Chesnutt BM, Utturkar G, Haggard WO, Yang Y, Ong JL, Bumgardner JD. The effect of cross-linking of chitosan microspheres with genipin on protein release. Carbohydr Polym 2007;68:561-567. (Pubitemid 46365939)
30. Muzzarelli RA. Reviews: Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell Mol Life Sci 1997;53:131-140.
31. Prashanth KH, Tharanathan RN. Depolymerized products of chitosan as potent inhibitors of tumor-induced angiogenesis. Biochim Biophys Acta 2005;1722:22-29.
32. Demierre MF. What about chemoprevention for melanoma? Curr Opin Oncol 2006;18:180-184.
33. Hussein MR, Haemel AK, Wood GS. Apoptosis and melanoma: Molecular mechanisms. J Pathol 2003;199:275-288. (Review article).
34. Rieber MS, Zangemeister-Wittke U, Rieber M. p53-independent induction of apoptosis in human melanoma cells by a bcl- 2/bcl-xL bispecific antisense oligonucleotide. Clin Cancer Res 2001;7:1446-1451. (Pubitemid 32708701)
35. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002;l:639-649.
36. Chen J, Freeman A, Liu J, Dai Q, Lee RM. The apoptotic effect of HA14-1, a Bcl-2-interacting small molecular compound, requires Bax translocation and is enhanced by PK11195. Mol Cancer Ther 2002;1:981-987.
37. Kim HJ, Park HJ, Park WS, Bae YM. CD43 cross-linking increases the Fas-induced apoptosis through induction of Fas aggregation in Jurkat T-cells. Exp Mol Med 2006;38:357-363. (Pubitemid 44351430)
38. Hersey P. Apoptosis and melanoma: How new insights are effecting the development of new therapies for melanoma. Curr Opin Oncol 2006;18:189-196. (Pubitemid 43740441)
39. Willingham MC. Cytochemical methods for the detection of apoptosis. J Histochem Cytochem 1999;47:1101-1109.
40. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, Lubin BH. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 1996;87:1179-1187. (Pubitemid 26043547)
41. Wang T, Turhan M, Gunasekaran S. Selected properties of pH-sensitive, biodegradable chitosan-poly(vinyl alcohol) hydrogel. Polym Int 2004;53:911-918. (Pubitemid 38884191)
42. Sun HX, Zhang L, Chai H, Chen HL. Surface modification of poly(tetrafluoroethylene) films via plasma treatment and graft copolymerization of acrylic acid. Desalination 2006;192:271-279.
43. Amaral IF, Granja PL, Melo LV, Saramago B, Barbosa MA. Functionalization of chitosan membranes through phosphorylation: Atomic force microscopy, wettability, and cytotoxicity studies. J Appl Polym Sci 2006;102:276-284. (Pubitemid 44518420)
44. Neamnark A, Sanchavanakit N, Pavasant P, Bunaprasert T, Supaphol P, Rujiravanit R. In vitro biocompatibility evaluations of hexanoyl chitosan film. Carbohydr Polym 2007;68: 166-172.
45. Vishu-Kumar AB, Gowda RL, Tharanathan RN. Non-specific depolymerization of chitosan by pronase and characterization of the resultant products. Eur J Biochem 2004;271:713-723.
46. Silvia RM, Silvia GA, Coutinho OP, Mano JF, Reis RL. Preparation and characterisation in simulated body conditions of glutaraldehyde crosslinked chitosan membranes. J Mater Sci: Mater Med 2004;15:1105-1112.
47. Findlay DM, Raggatt LJ, Bouralexis S, Hay S, Atkins GJ. Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism. J Endocrinol 2002;175:715-725. (Pubitemid 36054242)